510 related articles for article (PubMed ID: 22409779)
41. Emergence of antibiotic resistance during therapy for infections caused by Enterobacteriaceae producing AmpC beta-lactamase: implications for antibiotic use.
Choi SH; Lee JE; Park SJ; Choi SH; Lee SO; Jeong JY; Kim MN; Woo JH; Kim YS
Antimicrob Agents Chemother; 2008 Mar; 52(3):995-1000. PubMed ID: 18086837
[TBL] [Abstract][Full Text] [Related]
42. Risk factors of community-onset urinary tract infections caused by plasmid-mediated AmpC β-lactamase-producing Enterobacteriaceae.
Lee CH; Lee YT; Kung CH; Ku WW; Kuo SC; Chen TL; Fung CP
J Microbiol Immunol Infect; 2015 Jun; 48(3):269-75. PubMed ID: 24239065
[TBL] [Abstract][Full Text] [Related]
43. Prevalence and antimicrobial susceptibility data for extended-spectrum beta-lactamase- and AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997-2004).
Goossens H; Grabein B
Diagn Microbiol Infect Dis; 2005 Dec; 53(4):257-64. PubMed ID: 16360549
[TBL] [Abstract][Full Text] [Related]
44. Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae isolated from blood cultures in Africa.
Sangare SA; Maiga AI; Guindo I; Maiga A; Camara N; Savadogo S; Diallo S; Bougoudogo F; Armand-Lefevre L; Andremont A; Maiga II
Med Mal Infect; 2015 Sep; 45(9):374-82. PubMed ID: 26433872
[TBL] [Abstract][Full Text] [Related]
45. Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-beta-lactamase in a Greek University Hospital.
Souli M; Kontopidou FV; Papadomichelakis E; Galani I; Armaganidis A; Giamarellou H
Clin Infect Dis; 2008 Mar; 46(6):847-54. PubMed ID: 18269335
[TBL] [Abstract][Full Text] [Related]
46. Which proportion of extended-spectrum beta-lactamase producing strains could be treated by non-carbapenem beta-lactams?
Canoui E; Tankovic J; Bige N; Alves M; Offenstadt G
Med Mal Infect; 2014 May; 44(5):235-7. PubMed ID: 24780641
[No Abstract] [Full Text] [Related]
47. Colonisation and infection due to Enterobacteriaceae producing plasmid-mediated AmpC β-lactamases.
Rodríguez-Baño J; Miró E; Villar M; Coelho A; Gozalo M; Borrell N; Bou G; Conejo MC; Pomar V; Aracil B; Larrosa N; Agüero J; Oliver A; Fernández A; Oteo J; Pascual A; Navarro F
J Infect; 2012 Feb; 64(2):176-83. PubMed ID: 22138600
[TBL] [Abstract][Full Text] [Related]
48. ESBL- and Carbapenemase-Producing Enterobacteriaceae in Patients with Bacteremia, Yangon, Myanmar, 2014.
Myat TO; Hannaway RF; Zin KN; Htike WW; Win KK; Crump JA; Murdoch DR; Ussher JE
Emerg Infect Dis; 2017 May; 23(5):857-859. PubMed ID: 28418298
[TBL] [Abstract][Full Text] [Related]
49. Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay.
Rizvi M; Fatima N; Rashid M; Shukla I; Malik A; Usman A; Siddiqui S
J Infect Dev Ctries; 2009 May; 3(4):285-94. PubMed ID: 19759492
[TBL] [Abstract][Full Text] [Related]
50. Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay.
Rizvi M; Fatima N; Rashid M; Shukla I; Malik A; Usman A; Siddiqui S
J Infect Dev Ctries; 2009 Apr; 3(3):177-86. PubMed ID: 19759472
[TBL] [Abstract][Full Text] [Related]
51. Carbapenems Versus Piperacillin-Tazobactam for Bloodstream Infections of Nonurinary Source Caused by Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae.
Ofer-Friedman H; Shefler C; Sharma S; Tirosh A; Tal-Jasper R; Kandipalli D; Sharma S; Bathina P; Kaplansky T; Maskit M; Azouri T; Lazarovitch T; Zaidenstein R; Kaye KS; Marchaim D
Infect Control Hosp Epidemiol; 2015 Aug; 36(8):981-5. PubMed ID: 25990361
[TBL] [Abstract][Full Text] [Related]
52. Prevalence of extended spectrum beta-lactamase among multidrug resistant gram-negative isolates from a general hospital in Saudi Arabia.
Kader AA; Kumar AK
Saudi Med J; 2004 May; 25(5):570-4. PubMed ID: 15138522
[TBL] [Abstract][Full Text] [Related]
53. Efficacy of β-Lactam/β-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia.
Gudiol C; Royo-Cebrecos C; Abdala E; Akova M; Álvarez R; Maestro-de la Calle G; Cano A; Cervera C; Clemente WT; Martín-Dávila P; Freifeld A; Gómez L; Gottlieb T; Gurguí M; Herrera F; Manzur A; Maschmeyer G; Meije Y; Montejo M; Peghin M; Rodríguez-Baño J; Ruiz-Camps I; Sukiennik TC; Tebe C; Carratalà J;
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584145
[TBL] [Abstract][Full Text] [Related]
54. In vitro activities and detection performances of cefmetazole and flomoxef for extended-spectrum β-lactamase and plasmid-mediated AmpC β-lactamase-producing Enterobacteriaceae.
Matsumura Y; Yamamoto M; Nagao M; Tanaka M; Takakura S; Ichiyama S
Diagn Microbiol Infect Dis; 2016 Apr; 84(4):322-7. PubMed ID: 26782634
[TBL] [Abstract][Full Text] [Related]
55. Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Bahrain.
Bindayna KM; Senok AC; Jamsheer AE
J Infect Public Health; 2009; 2(3):129-35. PubMed ID: 20701872
[TBL] [Abstract][Full Text] [Related]
56. [Detection of bla(CTX-M) beta-lactamase genes in extended-spectrum beta-lactamase producing gram-negative bacteria].
Bayraktar B; Toksoy B; Bulut E
Mikrobiyol Bul; 2010 Apr; 44(2):187-96. PubMed ID: 20549952
[TBL] [Abstract][Full Text] [Related]
57. Role of empirical and targeted therapy in hospitalized patients with bloodstream infections caused by ESBL-producing Enterobacteriaceae.
Falcone M; Vena A; Mezzatesta ML; Gona F; Caio C; Goldoni P; Trancassini AM; Conti C; Orsi GB; Carfagna P; Stefani S; Venditti M
Ann Ig; 2014; 26(4):293-304. PubMed ID: 25001119
[TBL] [Abstract][Full Text] [Related]
58. Microbiological screening is necessary to distinguish carriers of plasmid-mediated AmpC beta-lactamase-producing enterobacteriaceae and extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae because of clinical similarity.
Conen A; Frei R; Adler H; Dangel M; Fux CA; Widmer AF
PLoS One; 2015; 10(3):e0120688. PubMed ID: 25803720
[TBL] [Abstract][Full Text] [Related]
59. The outcome of treating ESBL infections with carbapenems vs. non carbapenem antimicrobials.
Trivedi M; Patel V; Soman R; Rodriguez C; Singhal T
J Assoc Physicians India; 2012 Aug; 60():28-30. PubMed ID: 23405518
[TBL] [Abstract][Full Text] [Related]
60. Prevalence of extended-spectrum beta-lactamases in Enterobacteriaceae, Pseudomonas and Stenotrophomonas as determined by the VITEK 2 and E test systems in a Kuwait teaching hospital.
Jamal W; Rotimi VO; Khodakhast F; Saleem R; Pazhoor A; Al Hashim G
Med Princ Pract; 2005; 14(5):325-31. PubMed ID: 16103698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
